Kiora shareholders approve 1.5M share increase to 2024 equity incentive plan

KIORA PHARMACEUTICALS INC

Stockholders approved amendment to 2024 Equity Incentive Plan, increasing authorized shares by 1,500,000.
Lisa Walters-Hoffert, Aron Shapiro, and Praveen Tyle re-elected as Class II directors with >1M votes for each.
Non-binding advisory vote on executive compensation approved: 1,019,325 for, 21,670 against.
Ratification of Haskell & White LLP as auditor for FY 2026: 2,358,943 for, 5,403 against.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

KIORA PHARMACEUTICALS INC shareholders approved Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers at the 2026-06-10 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

The results of the vote were as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,019,325 21,670 4,674 1,320,660

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

KIORA PHARMACEUTICALS INC shareholders approved Election of Lisa Walters-Hoffert, Aron Shapiro, and Praveen Tyle as Class II Directors at the 2026-06-10 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

The results of the election were as follows: Name Votes For Votes Withheld Broker Non-Votes Lisa Walters-Hoffert 1,037,950 7,719 1,320,660 Aron Shapiro 1,030,543 15,126 1,320,660 Praveen Tyle, Ph.D. 1,029,403 16,266 1,320,660

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

KIORA PHARMACEUTICALS INC shareholders approved Approval of the amendment of the 2024 Equity Incentive Plan to increase the maximum number of shares authorized for issuance by 1,500,000 shares at the 2026-06-10 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

The results of the vote were as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 732,106 311,987 1,576 1,320,660

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

KIORA PHARMACEUTICALS INC shareholders approved Ratification of the appointment of Haskell & White LLP as the Company’s independent registered public accounting firm for fiscal year 2026 at the 2026-06-10 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

The results of the vote were as follows: Votes For Votes Against Votes Abstained 2,358,943 5,403 1,983

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

KIORA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001372514-26-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.